Octreotide (CAS: 79517-01-4)

Octreotide (CAS: 79517-01-4)

Octreotide (CAS: 79517-01-4) is a synthetic cyclic octapeptide, an analogue of natural somatostatin with prolonged pharmacological activity. It binds selectively to somatostatin receptors, inhibiting the secretion of growth hormone, insulin, glucagon, and various gastrointestinal peptides.
Send Inquiry
Description

Product Introduction

 

Octreotide (CAS: 79517-01-4) is a synthetic cyclic octapeptide, an analogue of natural somatostatin with prolonged pharmacological activity. It binds selectively to somatostatin receptors, inhibiting the secretion of growth hormone, insulin, glucagon, and various gastrointestinal peptides. Due to its stability and extended half-life, Octreotide is widely used in the treatment of acromegaly, carcinoid tumors, vasoactive intestinal peptide (VIP) tumors, and gastrointestinal bleeding.

 

Product Parameter (Specification)

 

Parameter

Description

Product Name

Octreotide

CAS No.

79517-01-4

Molecular Formula

C49H66N10O10S2

Molecular Weight

1019.25 g/mol

Purity

≥ 98% (HPLC)

Appearance

White to off-white powder

Solubility

Soluble in water and acetic acid

Storage

Store at −20°C, protected from light and moisture

Grade

Pharmaceutical grade

Shelf Life

2 years when properly stored

 

Product Feature and Application

 

  • Synthetic long-acting somatostatin analogue with strong receptor affinity.
  • Inhibits excessive secretion of growth hormone and gastrointestinal peptides.
  • Used clinically to treat acromegaly, carcinoid syndrome, and VIP-secreting tumors.
  • Also beneficial in managing variceal bleeding and postoperative pancreatic fistula.
  • Suitable for injectable formulations and peptide research applications.

 

Production Details

 

Octreotide is synthesized through advanced solid-phase peptide synthesis (SPPS) and purified via multiple chromatographic steps. Each production batch is tested for identity, purity, and potency using HPLC, LC–MS, and NMR. Manufacturing strictly follows GMP and ISO 9001 standards to ensure consistent pharmaceutical-grade quality.

 

Product Qualification

 

Our Octreotide is produced in GMP-certified facilities using high-purity amino acid raw materials. The process complies with international pharmacopoeial standards. Full analytical documentation-including COA, MSDS, and TDS-is available upon request. Each batch is validated for purity, stability, and bioactivity before shipment.

 

Delivery, Shipping and Serving

Packaging

1g, 10g, or customized quantities available.

Lead Time

3–5 working days after payment confirmation.

Shipping

Delivered via FedEx, DHL, or customer's preferred carrier under controlled temperature.

Support

Technical data, COA, and after-sales service are provided to ensure customer satisfaction.

 

FAQ

 

Q1: What are the main indications for Octreotide?

A1: Octreotide is mainly used for treating acromegaly, carcinoid tumors, and VIP-secreting tumors by reducing excessive hormone secretion.

Q2: How should Octreotide be stored?

A2: Store at −20 °C, protected from light and moisture. Keep sealed and dry for maximum stability.

Q3: Is Octreotide available in GMP quality?

A3: Yes, our Octreotide is produced under GMP-certified conditions and comes with complete COA and MSDS documentation.

 

Latest News

 

Our peptide product line includes a wide range of therapeutic and research-grade analogues such as Octreotide, Lanreotide, and Pasireotide. By combining advanced peptide synthesis technology with strict GMP quality control, we continue to deliver high-quality peptide APIs supporting endocrinology and oncology research worldwide.

 

Hot Tags: octreotide (cas: 79517-01-4), China octreotide (cas: 79517-01-4) manufacturers, suppliers